Immacule Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 115.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 40.98 Cr
as on 16-11-2024
- Company Age 14 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 250.00 Cr
as on 16-11-2024
- Satisfied Charges ₹ 54.70 Cr
as on 16-11-2024
- Revenue -20.97%
(FY 2023)
- Profit -88.26%
(FY 2023)
- Ebitda -48.08%
(FY 2023)
- Net Worth 109.10%
(FY 2023)
- Total Assets 38.81%
(FY 2023)
About Immacule Lifesciences
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 115.00 Cr and a paid-up capital of Rs 40.98 Cr.
The company currently has active open charges totaling ₹250.00 Cr. The company has closed loans amounting to ₹54.70 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Immacule Lifesciences Private Limited India are Ginny Uppal as COMPANY SECRETARY and Viral Shah as Ceo. Viral Shah and Vikas Sharma serve as directors at the Company.
- CIN/LLPIN
U74900HP2010PTC031676
- Company No.
031676
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Sep 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Immacule Lifesciences Private Limited offer?
Immacule Lifesciences Private Limited offers a wide range of products and services, including Plant Design & Installation Services, Industrial Design Services, Stained, Etched & Laminated Glass, Toughened Glass, Material Testing Labs & Services, Industrial Testing Service, Interior Designers, Interior Decorators.
Who are the key members and board of directors at Immacule Lifesciences?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Viral Shah | Managing Director | 20-Sep-2010 | Current |
Ginny Uppal | Company Secretary | 17-Oct-2024 | Current |
Board Members(1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vikas Sharma | Whole-Time Director | 31-Aug-2021 | Current |
Financial Performance of Immacule Lifesciences.
Immacule Lifesciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 20.97% decrease. The company also saw a substantial fall in profitability, with a 88.26% decrease in profit. The company's net worth Soared by an impressive increase of 109.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Immacule Lifesciences?
In 2023, Immacule Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Acme Generics Private LimitedActive 3 years 4 months
Viral Shah, Vikas Sharma and 1 more are mutual person
- Acme Formulation Private LimitedActive 20 years 6 months
Viral Shah, Vikas Sharma and 2 more are mutual person
- Ace Testing Solutions Private LimitedActive 15 years 23 days
Viral Shah and Vikas Sharma are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Hdfc Bank Limited Creation Date: 17 Aug 2023 | ₹150.00 Cr | Open |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 27 Jul 2023 | ₹75.00 Cr | Open |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 27 Jul 2023 | ₹25.00 Cr | Open |
How Many Employees Work at Immacule Lifesciences?
Immacule Lifesciences has a workforce of 543 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Immacule Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Immacule Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.